Member Info for Jarv55

Group Chief Executive Tareq Kawash commented: “Petrofac’s underlying business is robust with material growth in our backlog from approximately US$5.5 billion in new awards in new and traditional energy this year. This demonstrates our competitive strength and long-term potential. To deliver on this, we are working hard to address short-term liquidity challenges and strengthen the financial position of the Group. I am grateful for the continued efforts of our people, and the support of our clients and other stakeholders, as we work to deliver a positive future for Petrofac.”

Management has been making progress in organic actions to unwind working capital, collect receipts on ongoing and new contracts and to unlock long-outstanding commercial settlements. In addition, Management is considering the sale of non-core assets, and is actively engaged in discussions with financial investors to take a non-controlling position in certain other components of the business portfolio. As part of an overall plan, these transactions would result in a material improvement on the balance sheet. The Company is also exploring potential new financial options across all its classes of capital.

Shorts are closing fast here 10% closed since yesterday, they know it is going higher.

They are not going ot exercise warrants down here they need the price higher to do that https://invst.ly/12jyhy golden cross on the hourly would not be surprised to see more news this side of Xmas.

UPL good to see the move up on its way to fill the gap now. https://invst.ly/12jy0u

Have to say Slacker for someone who says they are holding at 40p its quite bizarre behaviour to not get behind the new Ceo, they have £2mill they can draw down they will get something out of the £1.2 mill just don't know how much and he is looking at applying for Medtech funds seriously listen to that interview it might make you feel less stressed.

Https://invst.ly/12jwh6 if this can break the 20ma its going to 12p https://invst.ly/12jwh6

The Board is examining a range of strategic and financial options with the objective of materially strengthening the Company’s balance sheet, securing bank guarantees and improving short-term liquidity. A key aim of this review is to protect the interests of Petrofac’s shareholders, creditors and employees while the Group continues its focus on safe and effective delivery for its clients.

Management has been making progress in organic actions to unwind working capital, collect receipts on ongoing and new contracts and to unlock long-outstanding commercial settlements. In addition, Management is considering the sale of non-core assets, and is actively engaged in discussions with financial investors to take a non-controlling position in certain other components of the business portfolio. As part of an overall plan, these transactions would result in a material improvement on the balance sheet. The Company is also exploring potential new financial options across all its classes of capital.

Group Chief Executive Tareq Kawash commented: “Petrofac’s underlying business is robust with material growth in our backlog from approximately US$5.5 billion in new awards in new and traditional energy this year. This demonstrates our competitive strength and long-term potential. To deliver on this, we are working hard to address short-term liquidity challenges and strengthen the financial position of the Group. I am grateful for the continued efforts of our people, and the support of our clients and other stakeholders, as we work to deliver a positive future for Petrofac.”

The Chairman René Médori commented: “The Board is fully focused on reviewing a range of strategic and financial options with the objectives of strengthening the Group’s balance sheet and protecting the interests of all our stakeholders. The appointment of Aidan de Brunner reinforces the skills and experience of the Board in support of these efforts.”

Petrofac will issue its pre-close trading update on 20 December 2023.

Further expansion of hearing loss test into the NHS

genedrive plc (AIM: GDR), the point of care Pharmacogenetic testing company, announces the Genedrive® MT-RNR1 ID Kit is now in routine use in the Trevor Mann Baby Unit ("TMBU") at the Royal Sussex County Hospital ("RSCH"), part of University Hospitals Sussex NHS Foundation Trust. This site is the second NHS Trust in the country to be using the Genedrive test for antibiotic induced hearing loss ("AIHL").

Each year approximately 450 babies are admitted to the neonatal unit in Brighton. The simple, non-invasive test will be used routinely to guide treatment prescription within the unit from today, 4 December 2023.

Inspiration Healthcare and Genedrive have been working closely with the team at the TMBU, providing training and support, to ensure the smooth implementation of the pharmacogenetic point of care test into the neonatal admission process. Every mother and child that comes to RSCH, will now have access to the life-changing test, should it be required.

James Cheek, Chief Executive Officer of genedrive plc, said: "Both children and parents in Sussex will have their lives and patient pathways enhanced by having access to this test. It also brings peace of mind and support to clinicians in very stressful circumstances to make the right decision for the patient. On a wider scale, it's great to see how rapid Pharmacogenetics testing is transforming healthcare in time-critical settings, and improving patient safety." Expect more hospitals to come on board.

Great to see Miri progressing well nice and steady.

Earl lol listen to the interview. https://www.youtube.com/watch?v=p0zyb3PE8E8&t=155s

Https://www.upstreamonline.com/exploration/target-date-established-for-crucial-offshore-gas-appraisal-well/2-1-1565875

Suggest everyone just reports Earl he is spamming on every bb

Petro needs to actually do some research, he thinks every stock is a pump and dump sad really going on every bb with the same message.

Slacker never nice when you see people being able to buy cheaper than your buy in price and I get your frustration, but if you listen to the presentation this new Ceo really is impressive. They haven't sugar coated anything, he practically said that there was no workable business model in place. Blame Budd for that. He is here to turn that around with his connections in the industry, look at who he has worked for and where, working in procurement and knowing what is needed to get the products into the NHS is priceless. Instead of continually bashing the company maybe look at the positives, you could actually get your cash back and some profits if they can get this adopted all over the UK. Yes its going to need cash all pharmas type companies do, but if they can get it rolled out in a research purpose capacity they will be selling it and getting revs coming in.

Well the bod are moving fast now, security is one of the main cirterias for the Sandbox. I wonder how much more revs the White label will bring in.

Angra Global started onboarding customers on 1 September 2023 and Semnet's cybersecurity expertise will enable the Company to build a dedicated cybersecurity team to support client onboarding and its operational activities, including the wider provision of white-label software solutions to global money service businesses.

Btc did not hit 45k

They could do with doing another interview to update us on the progess this year.

https://www.youtube.com/watch?v=WbJcD1uffzI

CloudWatcher to be fair it isn't on the website which is a little odd I have a screen shot of it, could of been from the Q and A presentation the one they didn't put on youtube.